IS THE A IN ANDA BEGINNING TO MEAN ANTITRUST?
The U.S. Food and Drug Administration (FDA) recently released two draft guidance documents related to its requirement for shared risk evaluation and mitigation strategies (REMS) and the process for requesting a waiver of this...more